Company / Total Assets
Lipocine Inc. Total Assets History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$17.0M
FY2025
5-year range
$17.0M / $52.5M
FY2021-FY2025
Trend
-24.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 4 consecutive years, from $52M in FY2021 to $17M in FY2025.
Based on SEC 10-K filings.
$17M in FY2025 with a 5-year CAGR of -7.7%.
Declined from $23M to $17M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -23.2%
- 5-Year CAGR
- -7.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Lipocine Inc.'s total assets has declined for 4 consecutive years.
- 5-year CAGR of -7.7%, indicating a declining trend.
- In FY2025, total assets decreased 24.5% year-over-year.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.0M | -24.5% |
| FY2024 | $22.5M | -2.1% |
| FY2023 | $23.0M | -38.7% |
| FY2022 | $37.5M | -28.5% |
| FY2021 | $52.5M | +107.0% |
| FY2020 | $25.4M | +29.0% |
| FY2019 | $19.7M | -5.7% |
| FY2018 | $20.9M | -54.8% |
| FY2013 | $46.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026